Home> Products> triple therapy inhalation formulation

{ "products": [ { "_id": "6864fe81c4418d1ebb0d08eb", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "STERIS DPI DEVICE", "description": "The STERIS DPI DEVICE is a modern, user-friendly Dry Powder Inhaler (DPI) designed to deliver respiratory medication directly to the lungs in a highly efficient and portable form. Inhalation therapy plays a critical role in the management of chronic respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). The DPI device simplifies this process by delivering the drug in the form of a dry powder without the need for coordination between actuation and inhalation, making it ideal for patients of all ages.\n\nWhat is a DPI Device?\nA Dry Powder Inhaler (DPI) is a medical device used to deliver therapeutic medication directly into the lungs. Unlike traditional inhalers that use propellants to push the drug into the lungs, DPI devices rely on the patient’s own inhalation power to disperse and inhale the powdered drug effectively. Essentially, a DPI device is a tool that administers medication in dry powder form to the lungs, providing quick and targeted respiratory relief.\n\nDPI Full Form: Dry Powder Inhaler\n\nUses of STERIS DPI DEVICE\nThe STERIS DPI DEVICE is commonly used in the treatment and management of respiratory diseases such as:\n\nAsthma\n\nChronic Obstructive Pulmonary Disease (COPD)\n\nBronchitis\n\nAllergic airway conditions\n\nIt helps deliver medication directly to the airways, ensuring faster action and reduced systemic side effects compared to oral treatments.\n\nHow It Works\nWhen the patient inhales through the mouthpiece, the device uses the airflow to disperse the dry powder into fine particles, allowing it to reach deep into the lungs. The inhaled medication begins working quickly to open airways, reduce inflammation, or treat infection, depending on the formulation used with the DPI.\n\nSide Effects of Dry Powder Inhaler Use\nWhile the STERIS DPI DEVICE itself is safe and user-friendly, some medications delivered via DPI may cause minor side effects such as:\n\nDry throat or mouth\n\nHoarseness\n\nCough\n\nIrritation in the throat\n\nFungal infections in the mouth (if corticosteroids are used and mouth is not rinsed after use)\n\nThese side effects can often be minimized with proper usage and hygiene.\n\nPrecautions Before Using STERIS DPI DEVICE\nAlways read the instructions carefully before first-time use.\n\nMake sure the device is clean and free from moisture.\n\nInhale deeply and forcefully to ensure proper medication delivery.\n\nDo not exhale into the device, as moisture can affect the powder's consistency.\n\nStore in a dry, cool place away from direct sunlight.\n\nAlways rinse your mouth after using corticosteroid-based powders.\n\nAdvantages of STERIS DPI DEVICE\nPropellant-free and eco-friendly\n\nPortable and compact design for daily use\n\nNo coordination required between inhalation and actuation\n\nDelivers medication effectively with minimal effort\n\nEasy-to-use, even for elderly or pediatric patients\n\nConclusion\nThe STERIS DPI DEVICE is a highly effective solution for individuals suffering from chronic or acute respiratory disorders. By delivering medication directly to the lungs in a dry powder form, it ensures fast relief, greater bioavailability, and improved patient compliance. Whether you’re managing asthma or COPD, this DPI device offers a dependable and convenient way to breathe easier every day.", "price": 255.0, "discountamount": 77.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "coordination required", "inhalation power", "inhalation making", "breathe easier", "individuals suffering", "compact design", "ecofriendly portable", "direct sunlight", "instructions carefully", "hygiene precautions", "proper usage", "medications delivered", "reach deep", "oral treatments", "critical role", "medical device", "patient inhales", "administers medication", "highly efficient", "respiratory diseases", "dpi device", "dry throat", "dry powder", "side effects", "moisture inhale deeply", "delivering medication directly", "lungs providing quick", "dry powder form", "chronic respiratory conditions", "pediatric patients conclusion", "dpi device offers", "dpi device simplifies", "steris dpi device", "dpi side effects", "youre managing asthma", "dry powder inhaler", "minor side effects", "improved patient compliance", "highly effective solution", "throat fungal infections", "dry cool place", "acute respiratory disorders", "minimal effort easytouse", "corticosteroidbased powders advantages", "powders consistency store", "treat infection depending", "fine particles allowing" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2142, "imageuri": "https://productimages.withfloats.com/actual/6864feb4c75fa610aeaeaeda.png", "tileimageuri": "https://productimages.withfloats.com/tile/6864feb4c75fa610aeaeaeda.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-02T09:40:17.078Z", "updatedon": "2025-07-02T13:03:34.654Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/steris-dpi-device/2142", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Dry powder inhaler", "category": "RESPIRTORYRANGE", "tags": [ "Dry powder inhaler" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6863d2854c1970de3d96ebcd", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "FLUTICATONE VILO 100", "description": "FLUTICATONE VILO 100 is a combination inhalation therapy designed to manage and control chronic respiratory conditions such as asthma and Chronic Obstructive Pulmonary Disease (COPD). This formulation contains two powerful agents: Fluticasone Furoate (100 mcg), a corticosteroid that reduces inflammation in the airways, and Vilanterol (25 mcg), a long-acting beta2-adrenergic agonist (LABA) that helps in bronchodilation by relaxing airway muscles. Together, they provide long-term relief from symptoms like wheezing, shortness of breath, and chest tightness.\n\nThis powder is administered via inhalation, allowing targeted action directly at the site of inflammation and constriction, making it an effective and fast-acting treatment choice for those suffering from persistent asthma or airflow obstruction in COPD.\n\nWhat is Fluticasone Furoate and Vilanterol Powder for Inhalation?\nFluticasone Furoate and Vilanterol Powder for Inhalation is a prescription medication used for long-term maintenance treatment of asthma and COPD in adults and adolescents. Fluticasone furoate is a synthetic corticosteroid that controls inflammation and swelling in the lungs. Vilanterol is a bronchodilator that improves breathing by relaxing muscles around the airways. The combination is not intended for acute bronchospasm relief but is ideal for daily use to manage chronic symptoms and prevent flare-ups.\n\nUses of Fluticasone Furoate and Vilanterol Powder for Inhalation\nLong-term control of asthma symptoms such as wheezing, coughing, and breathlessness\n\nMaintenance treatment of COPD, including chronic bronchitis and emphysema\n\nPrevention of asthma exacerbations and hospitalizations\n\nImprovement in lung function and quality of life in chronic respiratory patients\n\nRegular use of this inhaler can help reduce dependency on rescue inhalers and lower the frequency of asthma attacks or COPD exacerbations.\n\nFluticasone Furoate and Vilanterol Powder for Inhalation Side Effects\nWhile generally well-tolerated, some users may experience mild to moderate side effects including:\n\nHeadache\n\nThroat irritation\n\nHoarseness of voice\n\nOral thrush (fungal infection in the mouth)\n\nCough or upper respiratory tract infections\n\nIncreased heart rate or palpitations\n\nMuscle cramps or tremors\n\nRare allergic reactions like rash, itching, or swelling\n\nTo minimize the risk of oral thrush, it is advised to rinse the mouth thoroughly after each inhalation.\n\nPrecautions Before Using FLUTICATONE VILO 100\nDo not use it to treat sudden asthma attacks; it is not a rescue inhaler.\n\nInform your doctor if you have a history of heart disease, high blood pressure, diabetes, or liver problems.\n\nUse with caution in pregnancy and breastfeeding; consult your physician.\n\nRegular monitoring of lung function and adrenal activity is recommended during long-term use.\n\nChildren and adolescents may require special dose adjustments under medical supervision.\n\nDrug Interactions: What Drugs Interact with Fluticasone Furoate and Vilanterol?\nSeveral medications may interact with this combination and alter its effectiveness or increase the risk of side effects:\n\nBeta-blockers (e.g., propranolol): May reduce the bronchodilatory effect of vilanterol\n\nKetoconazole or Ritonavir: These strong CYP3A4 inhibitors can increase the levels of fluticasone in the blood, raising the risk of side effects\n\nDiuretics: May increase the risk of hypokalemia when used with vilanterol\n\nOther corticosteroids: Concurrent use may enhance systemic corticosteroid side effects\n\nMAO inhibitors and Tricyclic Antidepressants: May amplify cardiovascular effects\n\nAlways inform your healthcare provider about any medications, supplements, or herbal products you are taking before starting FLUTICATONE VILO 100.\n\nConclusion\nFLUTICATONE VILO 100 is a scientifically advanced, dual-action inhalation therapy that provides effective long-term control for asthma and COPD. With the anti-inflammatory strength of fluticasone furoate 100 mcg and the bronchodilating effect of vilanterol 25 mcg, this combination ensures better breathing, fewer flare-ups, and improved quality of life. It’s a reliable and essential component in the chronic respiratory care of patients who need consistent symptom control and lung function improvement.", "price": 525.0, "discountamount": 158.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "combination ensures", "improved quality", "medications supplements", "drugs interact", "mouth cough", "reduce dependency", "synthetic corticosteroid", "asthma attacks", "asthma exacerbations", "asthma symptoms", "persistent asthma", "vilanterol powder", "controls inflammation", "reduces inflammation", "vilanterol ketoconazole", "lungs vilanterol", "vilanterol 25 mcg", "essential component", "bronchodilating effect", "antiinflammatory strength", "herbal products", "healthcare provider", "tricyclic antidepressants", "corticosteroids concurrent", "blood raising", "bronchodilatory effect", "adrenal activity", "breastfeeding consult", "liver problems", "fluticatone vilo 100", "oral thrush", "rash itching", "experience mild", "generally welltolerated", "emphysema prevention", "wheezing coughing", "prescription medication", "airflow obstruction", "constriction making", "chest tightness", "wheezing shortness", "inhalation precautions", "rescue inhalers", "hospitalizations improvement", "prevent flareups", "improves breathing", "fluticasone furoate", "chronic bronchitis", "lung function", "relaxing muscles", "rescue inhaler inform", "adolescents fluticasone furoate", "manage chronic symptoms", "inhalation fluticasone furoate", "lung function improvement", "effective longterm control", "breathing fewer flareups", "inhalation longterm control", "relaxing airway muscles", "inhalation side effects", "longterm maintenance treatment", "provide longterm relief", "chronic respiratory care", "consistent symptom control", "amplify cardiovascular effects", "side effects diuretics", "strong cyp3a4 inhibitors", "side effects betablockers", "physician regular monitoring", "palpitations muscle cramps", "moderate side effects", "breathlessness maintenance treatment", "acute bronchospasm relief", "fastacting treatment choice" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2139, "imageuri": "https://productimages.withfloats.com/actual/6863d28eeb66715cb5e18de8.png", "tileimageuri": "https://productimages.withfloats.com/tile/6863d28eeb66715cb5e18de8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-01T12:20:21.253Z", "updatedon": "2025-07-01T12:28:46.31Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/fluticatone-vilo-100/2139", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "fluticasone furoate and vilanterol powder for inhalation", "category": "ASTHMARANGE", "tags": [ "fluticasone furoate and vilanterol powder for inhalation" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6661543edb9fdd21801ee843", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "R/C TIOTROPIN F ", "description": "R/C TIOTROPIN F \nTiotropium Bromide (18mcg)& Formoterol DH (12mcg) Powder for Inhalation\nR/C TIOTROPIN F is a potent combination of Tiotropium Bromide and Formoterol DH, designed for inhalation therapy. This powder formulation offers a convenient and effective way to manage respiratory conditions. Tiotropium Bromide, at 18mcg strength, acts as a long-acting anticholinergic bronchodilator, relaxing the muscles in the airways and improving airflow to the lungs. Formoterol DH, at 12mcg concentration, is a long-acting beta-agonist bronchodilator, providing additional bronchodilation and aiding in the prevention of bronchospasm.\n\nThis combination is particularly beneficial for individuals with chronic obstructive pulmonary disease (COPD) and asthma, helping to reduce symptoms such as shortness of breath, wheezing, and coughing. The powder form allows for easy administration through inhalation devices, ensuring precise dosing and rapid onset of action.\n\nConsult your healthcare provider for proper usage instructions and to determine if R/C TIOTROPIN F is suitable for your respiratory management needs. For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: \nhttps://www.sterisonline.com/product/r-c-tiotropin-f-133720\n\n\n\n\n\n\n", "price": 179.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Call", "COPD", "Email", "lungs", "action", "breath", "asthma", "airflow", "airways", "muscles", "symptoms", "coughing", "WhatsApp", "shortness", "convenient", "prevention", "individuals", "information", "rapid onset", "bronchospasm", "sterispharma", "sterisonline", "effective way", "Formoterol DH", "precise dosing", "18mcg strength", "R/C TIOTROPIN F", "potent combination", "powder formulation", "inhalation therapy", "Tiotropium Bromide", "inhalation devices", "healthcare provider", "easy administration", "12mcg concentration", "respiratory conditions", "proper usage instructions", "additional bronchodilation", "respiratory management needs", "acting beta-agonist bronchodilator", "acting anticholinergic bronchodilator", "chronic obstructive pulmonary disease" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1403, "imageuri": "https://productimages.withfloats.com/actual/666154404f159c14e1638d9a.png", "tileimageuri": "https://productimages.withfloats.com/tile/666154404f159c14e1638d9a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T06:16:30.536Z", "updatedon": "2024-06-29T10:41:25.157Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/r-c-tiotropin-f-/1403", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "R/C TIOTROPIN F ", "category": "ASTHMARANGE", "tags": [ "R/C TIOTROPIN F", "Tiotropium Bromide (18mcg)", "Formoterol DH (12mcg)", "Powder for Inhalation", "Tiotropium Bromide Inhaler 9 mcg", "Tiotropium bromide side effects", "Tiotropium Bromide Respules", "Tiotropium bromide dose" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6630cc3a3661c211fc3ef873", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "R.S. BUDEPRESS 0.5 ", "description": "R.S. BUDEPRESS 0.5 \nBudesonoid Respiratory Suspension (0.5mg)\nR.S. BUDEPRESS 0.5 is a pharmaceutical product containing Budesonide Respiratory Suspension at a concentration of 0.5mg. Budesonide is a corticosteroid medication used to treat asthma and other respiratory conditions by reducing inflammation in the airways. This suspension formulation is designed for inhalation therapy, delivering the medication directly to the lungs for optimal effectiveness. It helps alleviate symptoms such as wheezing, shortness of breath, and coughing associated with asthma. This product is intended for use under medical supervision and guidance.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \n", "price": 460.0, "discountamount": 138.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "lungs", "0.5mg", "breath", "asthma", "airways", "guidance", "wheezing", "symptoms", "coughing", "shortness", "inflammation", "concentration", "R.S. BUDEPRESS", "inhalation therapy", "medical supervision", "optimal effectiveness", "pharmaceutical product", "suspension formulation", "corticosteroid medication", "other respiratory conditions", "Budesonide Respiratory Suspension", "Budesonoid Respiratory Suspension" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 897, "imageuri": "https://productimages.withfloats.com/actual/6630cc3fc76b7398ff8388f6.png", "tileimageuri": "https://productimages.withfloats.com/tile/6630cc3fc76b7398ff8388f6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-30T10:47:22.384Z", "updatedon": "2024-06-12T12:00:30.787Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/r-s-budepress-0-5-/897", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Budesonoid Respiratory Suspension (0.5mg)", "category": "ASTHMARANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68e7a474f3481c1f16d3b038", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sitagliptin (50mg), Metformin Hydrochloride (500mg) & Glimepiride (2mg)", "description": "Sitagliptin 50mg, Metformin Hydrochloride 500mg & Glimepiride 2mg is a combination oral medication designed for the effective management of type 2 diabetes mellitus. This triple-action formula works synergistically to control blood glucose levels by addressing insulin resistance, enhancing insulin secretion, and regulating post-meal sugar spikes. Ideal for patients who require more than one mechanism to maintain stable blood sugar, this combination is often prescribed when monotherapy or dual therapy is insufficient.\n\nUses\n\nManagement of Type 2 Diabetes Mellitus in adults.\n\nHelps in controlling fasting and postprandial blood glucose levels.\n\nRecommended for patients whose blood sugar is not adequately controlled with a single antidiabetic medicine.\n\nCan be used as part of a comprehensive diabetes management plan, including diet and exercise.\n\nKey Benefits\n\nDual Mechanism Control:\n\nMetformin Hydrochloride reduces hepatic glucose production and improves insulin sensitivity.\n\nGlimepiride stimulates pancreatic beta cells to secrete more insulin.\n\nSitagliptin enhances incretin hormones, leading to better regulation of post-meal glucose levels.\n\nEffective Blood Sugar Management:\nHelps maintain optimal fasting and postprandial glucose levels, reducing the risk of diabetes-related complications.\n\nConvenient Combination Therapy:\nCombines three mechanisms in a single tablet, reducing the pill burden and improving patient compliance.\n\nSupports Overall Health:\nHelps prevent long-term complications such as neuropathy, nephropathy, retinopathy, and cardiovascular risks associated with diabetes.\n\nPossible Side Effects\n\nWhile generally well-tolerated, some patients may experience:\n\nGastrointestinal issues: nausea, vomiting, diarrhea, or abdominal discomfort (mainly from Metformin).\n\nHypoglycemia (low blood sugar): more likely due to Glimepiride; symptoms include dizziness, sweating, or shakiness.\n\nAllergic reactions: rash, itching, or swelling in rare cases.\n\nOther mild effects: headache, fatigue, or minor changes in taste.\n\nNote: Patients should always consult their doctor before starting this combination and report any unusual symptoms immediately.\n\nConclusion\n\nThe Sitagliptin, Metformin Hydrochloride & Glimepiride combination provides a powerful, multi-targeted approach to managing type 2 diabetes. By tackling high blood sugar from different angles, it supports better glucose control, enhances overall quality of life, and reduces the risk of diabetes-related complications. When used alongside proper diet, exercise, and medical guidance, this combination can be a cornerstone in effective diabetes management.", "price": 180.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2185, "imageuri": "https://productimages.withfloats.com/actual/68e7a47b040520d37b5e6b34.png", "tileimageuri": "https://productimages.withfloats.com/tile/68e7a47b040520d37b5e6b34.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-10-09T12:03:00.012Z", "updatedon": "2025-10-09T12:03:00.012Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sitagliptin-50mg-metformin-hydrochloride-500mg-glimepiride-2mg-/2185", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST GLIPTIN GM", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d51d9a26579f4bc195771a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimepiride IP1 mg, Voglibose IP 0.2 MG & Metformin Hydrochloride IP 500 mg ", "description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ", "price": 263.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2182, "imageuri": "https://productimages.withfloats.com/actual/68d51d9cdf1a4ca2c252370a.png", "tileimageuri": "https://productimages.withfloats.com/tile/68d51d9cdf1a4ca2c252370a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:46:50.098Z", "updatedon": "2025-10-02T11:20:20.402Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-ip1-mg-voglibose-ip-0-2-mg-metformin-hydrochloride-ip-500-mg-/2182", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d518ce6b4e65282a1dc798", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Formoterol Fumarate Dihydrate Ip 6 mcg & Budesonide IP 400 mcg", "description": "BUDESHINE F 400 CAP - This is a combination inhalation therapy used in the management of asthma and Chronic Obstructive Pulmonary Disease (COPD).\n\n \nMechanism of Action:\n\nFormoterol Fumarate: A long-acting β2-adrenergic agonist (LABA) that relaxes airway smooth muscles, providing rapid and sustained bronchodilation.\n\nBudesonide: An inhaled corticosteroid (ICS) that reduces airway inflammation, swelling, and mucus production.\n\nTogether, they offer dual action—quick relief of bronchospasm and long-term control of airway inflammation.\n\n \n\nIndications:\n\nAsthma (for patients not controlled adequately with inhaled corticosteroids alone).\n\nChronic Obstructive Pulmonary Disease (COPD) with reversible airway obstruction.\n\nPrevention of asthma attacks and reduction of COPD exacerbations.\n\n \n\nKey Benefits:\n\nProvides fast and sustained relief from breathing difficulty.\n\nControls both inflammation and bronchospasm.\n\nReduces the frequency and severity of asthma/COPD flare-ups.\n\nImproves overall lung function and quality of life.\n\n \nDosage and Administration:\n\nAdministered via inhalation as directed by a physician.\n\nDose depends on the severity of disease and patient response.\n\nRegular use is required for effective control—not for acute asthma attacks.\n(Exact dosing schedule to be prescribed by the doctor.)", "price": 238.0, "discountamount": 72.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2181, "imageuri": "https://productimages.withfloats.com/actual/68d518d1c1505f341d018bb1.png", "tileimageuri": "https://productimages.withfloats.com/tile/68d518d1c1505f341d018bb1.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:26:22.554Z", "updatedon": "2025-09-25T10:26:22.554Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/formoterol-fumarate-dihydrate-ip-6-mcg-budesonide-ip-400-mcg/2181", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "BUDESHINE F 400 CAP", "category": "ASTHMA RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68b0256b813270ffac595cb0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRELAQWK 100", "description": "TRELAQWK 100 is an advanced oral antidiabetic medication containing Trelagliptin 100 mg, specifically designed for adults with type 2 diabetes mellitus (T2DM). Belonging to the class of Dipeptidyl Peptidase-4 (DPP-4) inhibitors, this formulation helps improve blood glucose control when used along with a proper diet and regular exercise.\nWith its once-weekly dosage regimen, TRELAQWK 100 offers a convenient treatment option, enhancing patient compliance and simplifying long-term diabetes management.\nKey Ingredient\nTrelagliptin 100 mg\nA long-acting DPP-4 inhibitor that regulates blood glucose levels by enhancing incretin hormones. These incretins stimulate insulin secretion and suppress glucagon release, helping to achieve better glycemic control.\nKey Benefits of TRELAQWK 100\nWeekly dosing ensures greater convenience and adherence\nReduces both fasting and postprandial blood sugar levels\nSupports natural blood sugar regulation without weight gain\nLow risk of hypoglycemia, especially when used as monotherapy or with non-insulin therapies\nCan be prescribed as monotherapy or in combination with other antidiabetic agents like metformin or sulfonylureas\nHow TRELAQWK 100 Works\nTRELAQWK 100 functions by blocking the DPP-4 enzyme, which normally degrades incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide).\nThese incretin hormones:\nStimulate insulin secretion in response to meals\nReduce glucagon release, lowering blood sugar levels\nThanks to its extended half-life, trelagliptin allows for once-weekly dosing, unlike other DPP-4 inhibitors that require daily administration.\nDirections for Use\nDosage: Take one tablet of TRELAQWK 100 once weekly, or as directed by your physician\nAdministration: May be taken with or without food, ideally on the same day each week\nMissed dose: Do not double the dose; consult your healthcare provider for guidance\nPossible Side Effects\nTRELAQWK 100 is usually well-tolerated, but some individuals may experience:\nMild headache\nNasopharyngitis (common cold-like symptoms)\nConstipation\nUpper respiratory tract infections\nRare skin allergies (rash, itching)\n👉 If you experience persistent abdominal pain, severe rashes, or symptoms suggestive of pancreatitis, stop the medication and seek medical care immediately.", "price": 550.0, "discountamount": 165.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2166, "imageuri": "https://productimages.withfloats.com/actual/68b0256ebb42c3d551ad314c.png", "tileimageuri": "https://productimages.withfloats.com/tile/68b0256ebb42c3d551ad314c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-28T09:46:19.602Z", "updatedon": "2025-08-28T09:46:19.602Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trelaqwk-100/2166", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "trelagliptin 100 mg", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68b02393f5434d48fca8b8ca", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRELAQWK 50", "description": "TRELAQWK 50 is a modern oral antidiabetic tablet containing Trelagliptin 50 mg, specially developed for adults with type 2 diabetes mellitus. This once-weekly medication helps regulate blood sugar effectively, offering both convenience and strong clinical outcomes. With its advanced formulation, TRELAQWK 50 supports better glycemic control, making it easier for patients to lead a balanced and healthier lifestyle.\nManufactured under strict quality standards, TRELAQWK 50 ensures patient compliance, long-term safety, and efficacy in diabetes management.\nKey Ingredient\nTrelagliptin (50 mg):\nA unique, long-acting DPP-4 (dipeptidyl peptidase-4) inhibitor that allows weekly dosing, ensuring higher treatment adherence while maintaining effective control over blood glucose levels.\nKey Benefits of TRELAQWK 50\nProvides consistent blood sugar management with just one tablet per week\nEnhances insulin secretion while lowering glucagon levels in a glucose-dependent manner\nHelps reduce both fasting and postprandial blood glucose\nConvenient choice for patients with busy schedules who struggle with daily tablets\nLow risk of hypoglycemia when used as monotherapy\nSupports long-term improvement in HbA1c levels\nMechanism of Action – How TRELAQWK 50 Works\nTRELAQWK 50 works by blocking the DPP-4 enzyme, which normally degrades incretin hormones such as GLP-1 and GIP. These incretins are vital for maintaining blood sugar balance. By prolonging incretin activity, trelagliptin:\nStimulates insulin secretion from the pancreas\nReduces glucagon release from alpha cells\nHelps lower blood sugar, particularly after meals\nThis mechanism provides both effective glycemic control and improved patient compliance.\nDirections for Use\nTake one tablet of TRELAQWK 50 once a week, on the same day each week\nCan be taken with or without food\nSwallow whole with a glass of water\nFollow your doctor’s advice for dosage adjustment\nDo not double the dose if missed; consult your healthcare provider\nPossible Side Effects\nTRELAQWK 50 is usually well-tolerated. However, some patients may experience:\nMild headache\nNasopharyngitis (cold-like symptoms)\nDiarrhea\nStomach discomfort or indigestion\nRare allergic reactions (rash, itching)\nIf any unusual or persistent side effects occur, seek medical advice promptly.", "price": 375.0, "discountamount": 112.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2165, "imageuri": "https://productimages.withfloats.com/actual/68b023971624ba892ffd8c69.png", "tileimageuri": "https://productimages.withfloats.com/tile/68b023971624ba892ffd8c69.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-28T09:38:27.036Z", "updatedon": "2025-08-28T09:38:27.036Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trelaqwk-50/2165", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "trelagliptin 50 mg", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }